Literature DB >> 17609296

Exogenous testosterone alone or with finasteride does not improve measurements of cognition in healthy older men with low serum testosterone.

Camille Vaughan1, Felicia C Goldstein, J Lisa Tenover.   

Abstract

Testosterone (T) levels decline as men age, but it is unclear whether this has an effect on cognition. Some studies indicate that lower T levels are associated with memory loss; thus, maintaining a higher T level could have positive effects on aspects of cognitive function. Concerns exist, however, about the effect of T therapy on the prostate in older men. We hypothesized that T replacement in older men with low T levels would improve aspects of cognitive function and that the addition of finasteride would not affect the T-induced cognitive improvements. Healthy men, 65 to 83 years of age, with baseline total T below 350 ng/dL and no evidence of cognitive impairment were randomly assigned to 1 of 3 regimens: 200 mg of T every 2 weeks by intramuscular injection with placebo pill daily (T-only), 200 mg of T every 2 weeks by intramuscular injection with 5 mg of finasteride daily (T+F), or placebo injections and pills (placebo). Sixty-nine men completed baseline cognitive testing; 65 completed at least 4 months, and 46 completed all 36 months of the study. Participants were given a battery of cognitive evaluations at baseline, 4 months, and 36 months, along with measurement of serum hormone levels. Serum total T, bioavailable T, and estradiol levels in the T-only and T+F groups significantly increased throughout the treatment period, whereas these hormone levels did not change in the placebo group. Only minimally significant differences were seen among the 3 groups in any evaluation of cognitive performance, either in the short-term (4 months) or the long-term (36 months) analysis. These results indicate that T replacement, whether given alone or in combination with finasteride, for 36 months in healthy older men without cognitive impairment at baseline has no clinically significant effect on tests of cognitive function. Further studies are warranted to determine whether hormone replacement in men with preexisting cognitive impairment is beneficial.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17609296     DOI: 10.2164/jandrol.107.002931

Source DB:  PubMed          Journal:  J Androl        ISSN: 0196-3635


  28 in total

1.  The Testosterone Trials: Seven coordinated trials of testosterone treatment in elderly men.

Authors:  Peter J Snyder; Susan S Ellenberg; Glenn R Cunningham; Alvin M Matsumoto; Shalender Bhasin; Elizabeth Barrett-Connor; Thomas M Gill; John T Farrar; David Cella; Raymond C Rosen; Susan M Resnick; Ronald S Swerdloff; Jane A Cauley; Denise Cifelli; Laura Fluharty; Marco Pahor; Kristine E Ensrud; Cora E Lewis; Mark E Molitch; Jill P Crandall; Christina Wang; Matthew J Budoff; Nanette K Wenger; Emile R Mohler; Diane E Bild; Nakela L Cook; Tony M Keaveny; David L Kopperdahl; David Lee; Ann V Schwartz; Thomas W Storer; William B Ershler; Cindy N Roy; Leslie J Raffel; Sergei Romashkan; Evan Hadley
Journal:  Clin Trials       Date:  2014-06       Impact factor: 2.486

2.  Testosterone replacement attenuates cognitive decline in testosterone-deprived lean rats, but not in obese rats, by mitigating brain oxidative stress.

Authors:  Hiranya Pintana; Wanpitak Pongkan; Wasana Pratchayasakul; Nipon Chattipakorn; Siriporn C Chattipakorn
Journal:  Age (Dordr)       Date:  2015-08-16

Review 3.  Protective actions of sex steroid hormones in Alzheimer's disease.

Authors:  Christian J Pike; Jenna C Carroll; Emily R Rosario; Anna M Barron
Journal:  Front Neuroendocrinol       Date:  2009-05-07       Impact factor: 8.606

Review 4.  Preventing cognitive decline in healthy older adults.

Authors:  Raza Naqvi; Dan Liberman; Jarred Rosenberg; Jillian Alston; Sharon Straus
Journal:  CMAJ       Date:  2013-04-15       Impact factor: 8.262

5.  Testosterone Treatment and Cognitive Function in Older Men With Low Testosterone and Age-Associated Memory Impairment.

Authors:  Susan M Resnick; Alvin M Matsumoto; Alisa J Stephens-Shields; Susan S Ellenberg; Thomas M Gill; Sally A Shumaker; Debbie D Pleasants; Elizabeth Barrett-Connor; Shalender Bhasin; Jane A Cauley; David Cella; Jill P Crandall; Glenn R Cunningham; Kristine E Ensrud; John T Farrar; Cora E Lewis; Mark E Molitch; Marco Pahor; Ronald S Swerdloff; Denise Cifelli; Stephen Anton; Shehzad Basaria; Susan J Diem; Christina Wang; Xiaoling Hou; Peter J Snyder
Journal:  JAMA       Date:  2017-02-21       Impact factor: 56.272

Review 6.  Effects of Testosterone Therapy on Cognitive Function in Aging: A Systematic Review.

Authors:  Jeremy T Hua; Kerry L Hildreth; Victoria S Pelak
Journal:  Cogn Behav Neurol       Date:  2016-09       Impact factor: 1.600

7.  Cognition is not modified by large but temporary changes in sex hormones in men.

Authors:  Laura A Young; Michelle B Neiss; Mary H Samuels; Charles E Roselli; Jeri S Janowsky
Journal:  J Clin Endocrinol Metab       Date:  2009-10-30       Impact factor: 5.958

Review 8.  Risks and benefits of testosterone therapy in older men.

Authors:  Matthew Spitzer; Grace Huang; Shehzad Basaria; Thomas G Travison; Shalender Bhasin
Journal:  Nat Rev Endocrinol       Date:  2013-04-16       Impact factor: 43.330

9.  Treatment of Men for "Low Testosterone": A Systematic Review.

Authors:  Samantha Huo; Anthony R Scialli; Sean McGarvey; Elizabeth Hill; Buğra Tügertimur; Alycia Hogenmiller; Alessandra I Hirsch; Adriane Fugh-Berman
Journal:  PLoS One       Date:  2016-09-21       Impact factor: 3.240

10.  Serum testosterone levels and mortality in men with CKD stages 3-4.

Authors:  Kiranpreet K Khurana; Sankar D Navaneethan; Susana Arrigain; Jesse D Schold; Joseph V Nally; Daniel A Shoskes
Journal:  Am J Kidney Dis       Date:  2014-04-13       Impact factor: 8.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.